22-19523532-C-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001363066.2(CLDN5):c.*67G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 1,484,968 control chromosomes in the GnomAD database, including 15,172 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 1957 hom., cov: 34)
Exomes 𝑓: 0.14 ( 13215 hom. )
Consequence
CLDN5
NM_001363066.2 3_prime_UTR
NM_001363066.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.104
Genes affected
CLDN5 (HGNC:2047): (claudin 5) This gene encodes a member of the claudin family. Claudins are integral membrane proteins and components of tight junction strands. Tight junction strands serve as a physical barrier to prevent solutes and water from passing freely through the paracellular space between epithelial or endothelial cell sheets. Mutations in this gene have been found in patients with velocardiofacial syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, May 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 22-19523532-C-A is Benign according to our data. Variant chr22-19523532-C-A is described in ClinVar as [Benign]. Clinvar id is 1224832.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.297 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLDN5 | NM_001363066.2 | c.*67G>T | 3_prime_UTR_variant | Exon 1 of 1 | ENST00000618236.2 | NP_001349995.1 | ||
CLDN5 | NM_001130861.1 | c.*67G>T | 3_prime_UTR_variant | Exon 1 of 1 | NP_001124333.1 | |||
CLDN5 | NM_001363067.2 | c.*67G>T | 3_prime_UTR_variant | Exon 2 of 2 | NP_001349996.1 | |||
CLDN5 | NM_003277.4 | c.*67G>T | 3_prime_UTR_variant | Exon 2 of 2 | NP_003268.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLDN5 | ENST00000618236 | c.*67G>T | 3_prime_UTR_variant | Exon 1 of 1 | NM_001363066.2 | ENSP00000480623.1 | ||||
CLDN5 | ENST00000403084 | c.*67G>T | 3_prime_UTR_variant | Exon 1 of 1 | ENSP00000384554.1 | |||||
CLDN5 | ENST00000406028 | c.*67G>T | 3_prime_UTR_variant | Exon 2 of 2 | 2 | ENSP00000385477.1 | ||||
CLDN5 | ENST00000413119 | c.*67G>T | 3_prime_UTR_variant | Exon 2 of 2 | 2 | ENSP00000400612.2 |
Frequencies
GnomAD3 genomes AF: 0.153 AC: 23229AN: 152110Hom.: 1958 Cov.: 34
GnomAD3 genomes
AF:
AC:
23229
AN:
152110
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.136 AC: 181610AN: 1332740Hom.: 13215 Cov.: 30 AF XY: 0.136 AC XY: 89013AN XY: 652400
GnomAD4 exome
AF:
AC:
181610
AN:
1332740
Hom.:
Cov.:
30
AF XY:
AC XY:
89013
AN XY:
652400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.153 AC: 23232AN: 152228Hom.: 1957 Cov.: 34 AF XY: 0.154 AC XY: 11432AN XY: 74444
GnomAD4 genome
AF:
AC:
23232
AN:
152228
Hom.:
Cov.:
34
AF XY:
AC XY:
11432
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
682
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Apr 19, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at